StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)
StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report released on Sunday. The firm issued a sell rating on the stock. Separately, HC Wainwright restated a buy rating and set a $3.00 price objective on shares of Moleculin Biotech in a report on Thursday, December 14th. Get Our […]
More Stories
Federal Reserve Keeps Interest Rates Unchanged, Signals 2 Cuts This year
By Andrew Moran The Federal Reserve kept interest rates unchanged for the fourth straight meeting on June 18, a decision...
Elon Musk’s X Sues New York Over Content-Moderation Law
By Bill Pan Elon Musk’s social media platform X is suing New York state over a new law that would...
Zero Illegal Immigrants Released Into US in May: CBP
By Naveen Athrappully Border Patrol released no illegal immigrants into the country in May, a “staggering drop” from the more...
Panthers Repeat as Stanley Cup Champions, Beat Oilers in 6 Games
By The Associated Press SUNRISE, Fla.—Stanley’s stay in South Florida is getting extended. The Florida Panthers repeated as Stanley Cup...
Karen Read’s 2nd Trial Ends With Not Guilty Verdict on Murder Charge
By Bill Pan A Massachusetts jury on Wednesday found Karen Read not guilty in the death of her boyfriend, Boston...
General Mills Announces Removal of Synthetic Food Dyes, Starting With Cereals
By Naveen Athrappully General Mills, which owns a wide range of snack and baked products in the United States, announced...